|  | |
| Clinical data | |
|---|---|
| Other names | Probarbital, Ipral, Vasalgin, 5-Isopropyl-5-ethylbarbituric acid | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 
 | 
| PubChem CID | |
| ChemSpider | 
 | 
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C9H14N2O3 | 
| Molar mass | 198.222 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|  N  Y (what is this?)  (verify) | |
Probarbital (trade names Ipral, Vasalgin) is a barbiturate derivative invented in the 1920s. It has sedative, hypnotic and anticonvulsant properties.
References
| Alcohols | |
|---|---|
| Barbiturates | 
 | 
| Benzodiazepines | 
 | 
| Carbamates | |
| Flavonoids | |
| Imidazoles | |
| Kava constituents | 
 | 
| Monoureides | 
 | 
| Neuroactive steroids | 
 | 
| Nonbenzodiazepines | |
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases | 
 | 
| Others/unsorted | 
 
 | 
| See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators | |
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.